Evidence map›Paper›PMID 35418754›Full record

ArticleInternational journal of nanomedicine2022

Characterization of Silver Nanoparticles Synthesized by Leaves of

Yu Zhang, Li Cui, Yizeng Lu, Jixiang He, Hidayat Hussain, Lei Xie, Xuan Sun, Zhaoqing Meng, Guiyun Cao, Dawei Qin and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in oncology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Yu Zhang *School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, People's Republic of China.
Li Cui *School of Pharmaceutical Sciences and Key Laboratory for Applied Technology of Sophisticated Analytical Instruments of Shandong Province, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, People's Republic of China.
Yizeng LuShandong Provincial Center of Forest and Grass Germplasm Resources, Jinan, 250102, People's Republic of China.
Jixiang HeSchool of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250353, People's Republic of China.
Hidayat HussainDepartment of Bioorganic Chemistry, Leibniz Institute of Plant BioChemistry, Halle, D-06120, Germany.
Lei XieShandong Provincial Center of Forest and Grass Germplasm Resources, Jinan, 250102, People's Republic of China.
Xuan SunSchool of Pharmaceutical Sciences and Key Laboratory for Applied Technology of Sophisticated Analytical Instruments of Shandong Province, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, People's Republic of China.
Zhaoqing MengShandong Hongjitang Pharmaceutical Group Co., Ltd., Jinan, 250103, People's Republic of China.
Guiyun CaoShandong Hongjitang Pharmaceutical Group Co., Ltd., Jinan, 250103, People's Republic of China.
Dawei QinSchool of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250353, People's Republic of China.
Daijie WangSchool of Pharmaceutical Sciences and Key Laboratory for Applied Technology of Sophisticated Analytical Instruments of Shandong Province, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, People's Republic of China.
Qilu University of Technology · CNBuchang Pharma (China) · CNShandong Academy of Sciences · CNLeibniz Institute of Plant Biochemistry · DEShandong University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The leaves of Methods: LLJ was used as a reducing agent to produce the LLJ-mediated silver nanoparticles (LLJ-AgNPs). The structure and physicochemical properties of LLJ-AgNPs were characterized by ultraviolet spectroscopy (UV-Vis), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), and x-ray powder diffraction (XRD). Antioxidant activity of LLJ-AgNPs was determined by 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging. Antibacterial activity was determined by 96 well plates (AGAR) gradient dilution, while the anticancer potential was determined by MTT assay. Results: The results showed LLJ-AgNPs had a spherical structure with the maximum UV-Vis absorption at 400 nm. In addition, LLJ-AgNPs exhibited excellent antioxidant properties, where the free radical scavenging rate of LLJ-AgNPs was increased from 39% to 92% at concentrations from 0.25 to 1.0 mg/mL. Moreover, LLJ-AgNPs displayed excellent antibacterial properties against Conclusion: The present study provides a green approach to synthesize LLJ-AgNPs. All those findings illustrated that the produced LLJ-AgNPs can be used as an economical and efficient functional material for further applications in food and pharmaceutical fields.

Indexed as

LoniceraMetal NanoparticlesAnti-Bacterial AgentsAntioxidantsEscherichia coliHeLa CellsHumansPlant ExtractsPlant LeavesSilverSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAnti-Bacterial AgentsAntioxidantsPlant ExtractsSilverantibacterialanticancerantioxidantgreen approachleaves of Lonicera japonica ThunbLLJ-AgNO3-NPs

Identifiers

PMID35418754
PMCPMC8995626
OpenAlexW4226300351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.